Zoetis Inc., ZTS is in the exchange NYSE and its industry is Drugs – Generic in the sector of Healthcare. Based in USA, Zoetis Inc., ZTS has a market cap of 24071.04. Since its IPO date on the 2/1/2013, Zoetis Inc., ZTS performance year to date is 1.86%. Today Zoetis Inc., ZTS has gained 1.70%, with a current price of 48.5.
Ownership of the company is 0.01% for insider ownership while institutional ownership is 95.10%. The management of the company have seen the company have a payout ratio of 46.90%. Return of assets are at 5.30%, with return on investment at 5.70%.
In terms of debt levels and profit levels, Zoetis Inc., ZTS is seeing a long-term debt/equity of 3.83. While Total debt/equity is 3.84. With a profit margin of 7.80%, this is combined with a gross margin of 64.10%, and operating margin of 13.40%. Zoetis Inc. ability to meet debt levels, with a current ratio of 2.8, while the quick ratio is 1.6.
For the last year Zoetis Inc., ZTS has seen a EPS growth of -41.90%. A performance for the year of 5.19%. The 52-week high is -2.79%, and the 52-week low is 29.61%. The average volume for Zoetis Inc., ZTS is 2851869.
With a target price of 52.7, can Zoetis Inc., ZTS reach this target? Looking at the value indicators of Zoetis Inc., ZTS. Zoetis Inc. has a P/E of 64.07 and a forward P/E of 21.12. Perhaps the more useful indicator than P/E, is PEG which has a value of 5.09. Zoetis Inc. also has a P/S and a P/B of 4.99 and 20.73 respectively. For P/cash, Zoetis Inc. has a value of 35.66, while it is 93.3 for P/free cash flow.
At the current price of 48.5, Zoetis Inc. has a dividend yield of 0.78%. We see a return on equity of 32.60%.
Looking more long-term Zoetis Inc., is projected to get an EPS growth for the next five years of 12.58%. In the short-term an EPS growth of 22.91% in the next year is forecasted. This is after a EPS growth of -41.90% for this year and for the last five years a 25.10% growth has been seen.